• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SHP-1在T细胞抗原受体信号传导中对ZAP-70的直接调控。

Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling.

作者信息

Plas D R, Johnson R, Pingel J T, Matthews R J, Dalton M, Roy G, Chan A C, Thomas M L

机构信息

Howard Hughes Medical Institute, Center for Immunology, Washington University Medical School, St Louis, Missouri 63110, USA.

出版信息

Science. 1996 May 24;272(5265):1173-6. doi: 10.1126/science.272.5265.1173.

DOI:10.1126/science.272.5265.1173
PMID:8638162
Abstract

The threshold at which antigen triggers lymphocyte activation is set by the enzymes that regulate tyrosine phosphorylation. Upon T cell activation, the protein tyrosine phosphatase SHP-1 was found to bind to the protein tyrosine kinase ZAP-70. This interaction resulted in an increase in SHP-1 phosphatase activity and a decrease in ZAP-70 kinase activity. Expression of a dominant negative mutant of SHP-1 in T cells increased the sensitivity of the antigen receptor. Thus, SHP-1 functions as a negative regulator of the T cell antigen receptor and in setting the threshold of activation.

摘要

抗原触发淋巴细胞激活的阈值由调节酪氨酸磷酸化的酶设定。在T细胞激活后,发现蛋白酪氨酸磷酸酶SHP-1与蛋白酪氨酸激酶ZAP-70结合。这种相互作用导致SHP-1磷酸酶活性增加,ZAP-70激酶活性降低。在T细胞中表达SHP-1的显性负性突变体增加了抗原受体的敏感性。因此,SHP-1作为T细胞抗原受体的负调节因子,并在设定激活阈值中发挥作用。

相似文献

1
Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling.SHP-1在T细胞抗原受体信号传导中对ZAP-70的直接调控。
Science. 1996 May 24;272(5265):1173-6. doi: 10.1126/science.272.5265.1173.
2
Hematopoietic cell phosphatase (HCP) regulates p56LCK phosphorylation and ZAP-70 binding to T cell receptor zeta chain.造血细胞磷酸酶(HCP)调节p56LCK磷酸化以及ZAP-70与T细胞受体ζ链的结合。
Biochem Biophys Res Commun. 1996 May 6;222(1):50-7. doi: 10.1006/bbrc.1996.0696.
3
TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells.转化生长因子-β通过上调T细胞中的酪氨酸磷酸酶来消除T细胞受体介导的信号传导。
Shock. 2001 Mar;15(3):193-9. doi: 10.1097/00024382-200115030-00006.
4
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.细胞毒性T淋巴细胞相关抗原4(CTLA-4)通过抑制ζ链相关蛋白激酶70(ZAP-70)酪氨酸(Tyr)319位点的磷酸化来抑制静息人CD4(+) T细胞中的近端T细胞受体(TCR)信号传导:酪氨酸磷酸酶的潜在作用
J Immunol. 2002 May 1;168(9):4420-9. doi: 10.4049/jimmunol.168.9.4420.
5
Molecular basis of T cell inactivation by CTLA-4.CTLA-4介导T细胞失活的分子基础。
Science. 1998 Dec 18;282(5397):2263-6. doi: 10.1126/science.282.5397.2263.
6
CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.CD5负向调节T细胞抗原受体信号转导通路:含SH2结构域的磷酸酪氨酸磷酸酶SHP-1的参与。
Mol Cell Biol. 1999 Apr;19(4):2903-12. doi: 10.1128/MCB.19.4.2903.
7
Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.对接蛋白Gab2被ZAP-70磷酸化,并通过募集抑制性分子负向调节T细胞受体信号传导。
J Biol Chem. 2001 Nov 30;276(48):45175-83. doi: 10.1074/jbc.M105384200. Epub 2001 Sep 25.
8
Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.Src激酶对细胞毒性T淋巴细胞相关分子4的调控
J Immunol. 1999 Feb 1;162(3):1270-7.
9
Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.酪氨酸磷酸酶SYP与CTLA-4结合对T细胞受体信号传导的调节
Science. 1996 May 24;272(5265):1170-3. doi: 10.1126/science.272.5265.1170.
10
Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling.Sam68与Src家族酪氨酸激酶Fyn和Lck在T细胞受体信号传导中的相互作用。
J Biol Chem. 1997 Mar 7;272(10):6214-9. doi: 10.1074/jbc.272.10.6214.

引用本文的文献

1
The phosphatases TCPTP, PTPN22, and SHP1 play unique roles in T cell phosphotyrosine maintenance and feedback regulation of the TCR.磷酸酶TCPTP、PTPN22和SHP1在T细胞磷酸酪氨酸维持及TCR的反馈调节中发挥独特作用。
Sci Rep. 2025 Jul 30;15(1):27747. doi: 10.1038/s41598-025-12951-2.
2
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.脾酪氨酸激酶(SYK)负向调节免疫受体酪氨酸活化基序(ITAM)介导的人自然杀伤(NK)细胞信号传导及CD19嵌合抗原受体(CAR)NK细胞的功效。
J Immunol. 2025 Mar 9;214(3):384-98. doi: 10.1093/jimmun/vkaf012.
3
Adaptive immune cells antagonize ILC2 homeostasis via SLAMF3 and SLAMF5.
适应性免疫细胞通过信号淋巴细胞激活分子家族3(SLAMF3)和信号淋巴细胞激活分子家族5(SLAMF5)拮抗2型固有淋巴细胞(ILC2)的稳态。
Sci Adv. 2025 Jan 10;11(2):eadp9894. doi: 10.1126/sciadv.adp9894.
4
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations.西方人群中与1型人类嗜T淋巴细胞病毒相关的成人T细胞白血病-淋巴瘤的独特基因组特征。
Haematologica. 2024 Dec 1;109(12):4021-4039. doi: 10.3324/haematol.2024.285233.
5
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.PD-1/LAG-3 共信号通路分析揭示 CBL 泛素连接酶为免疫治疗的关键靶点。
EMBO Mol Med. 2024 Aug;16(8):1791-1816. doi: 10.1038/s44321-024-00098-y. Epub 2024 Jul 19.
6
Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.脾酪氨酸激酶(SYK)负向调节ITAM介导的人自然杀伤细胞信号传导及CD19嵌合抗原受体自然杀伤细胞的效能。
bioRxiv. 2024 Jul 13:2024.07.09.602676. doi: 10.1101/2024.07.09.602676.
7
Consideration of SHP-1 as a Molecular Target for Tumor Therapy.考虑将 SHP-1 作为肿瘤治疗的分子靶点。
Int J Mol Sci. 2023 Dec 26;25(1):331. doi: 10.3390/ijms25010331.
8
Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection.在黑色素瘤中打破 NGF-TrkA 免疫抑制作用可增强免疫疗法以持久保护记忆 T 细胞。
Nat Immunol. 2024 Feb;25(2):268-281. doi: 10.1038/s41590-023-01723-7. Epub 2024 Jan 9.
9
Protein tyrosine phosphatases as emerging targets for cancer immunotherapy.蛋白酪氨酸磷酸酶作为癌症免疫治疗的新兴靶点。
Br J Pharmacol. 2023 Dec 20. doi: 10.1111/bph.16304.
10
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.CD3ζ ITAMs 通过抑制 TCR 信号转导来响应低亲和力肽,从而实现配体的区分和拮抗。
Nat Immunol. 2023 Dec;24(12):2121-2134. doi: 10.1038/s41590-023-01663-2. Epub 2023 Nov 9.